Show simple item record

dc.contributor.authorGimeno, Lourdes
dc.contributor.authorSerrano-López, Emilio M.
dc.contributor.authorCampillo, José A.
dc.contributor.authorCánovas-Zapata, María A.
dc.contributor.authorAcuña, Omar S.
dc.contributor.authorGarcía Cózar, Francisco José 
dc.contributor.authorMartínez-Sánchez, María V.
dc.contributor.authorMartínez-Hernández, María D.
dc.contributor.authorSoto-Ramírez, María F.
dc.contributor.authorLópez-Cubillana, Pedro
dc.contributor.authorMartínez-Escribano, Jorge
dc.contributor.authorMartínez-García, Jerónimo
dc.contributor.authorCorbalan-García, Senena
dc.contributor.authorÁlvarez-López, María R.
dc.contributor.authorMinguela, Alfredo
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2020-12-16T12:12:43Z
dc.date.available2020-12-16T12:12:43Z
dc.date.issued2020-10
dc.identifier.issn2072-6694
dc.identifier.urihttp://hdl.handle.net/10498/24071
dc.description.abstractKiller-cell immunoglobulin-like receptors (KIR) are molecules expressed by the most important cells of the immune system for cancer immune vigilance, natural killer (NK) and effector T cells. In this manuscript we study the role that cytotoxic CD8+ T cells expressing KIR receptors could play in cancer immune surveillance. With this objective, frequencies of different KIR+ CD8+ T cell subsets are correlated with the overall survival of patients with melanoma, ovarian and bladder carcinomas. In addition, the gene expression profile of KIR+ CD8+ T cell subsets related to the survival of patients is studied with the aim of discovering new therapeutic targets, so that the outcome of patients with cancer can be improved. Killer-cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) and effector T cells. Although KIR+ T cells accumulate in oncologic patients, their role in cancer immune response remains elusive. This study explored the role of KIR+CD8+ T cells in cancer immunosurveillance by analyzing their frequency at diagnosis in the blood of 249 patients (80 melanomas, 80 bladder cancers, and 89 ovarian cancers), their relationship with overall survival (OS) of patients, and their gene expression profiles. KIR2DL1+ CD8+ T cells expanded in the presence of HLA-C2-ligands in patients who survived, but it did not in patients who died. In contrast, presence of HLA-C1-ligands was associated with dose-dependent expansions of KIR2DL2/S2+ CD8+ T cells and with shorter OS. KIR interactions with their specific ligands profoundly impacted CD8+ T cell expression profiles, involving multiple signaling pathways, effector functions, the secretome, and consequently, the cellular microenvironment, which could impact their cancer immunosurveillance capacities. KIR2DL1/S1+ CD8+ T cells showed a gene expression signature related to efficient tumor immunosurveillance, whereas KIR2DL2/L3/S2+CD8+ T cells showed transcriptomic profiles related to suppressive anti-tumor responses. These results could be the basis for the discovery of new therapeutic targets so that the outcome of patients with cancer can be improved.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceCancers 2020, 12(10), 2991es_ES
dc.subjectcanceres_ES
dc.subjectCD8+T cellses_ES
dc.subjectKIRes_ES
dc.subjectimmunosurveillancees_ES
dc.subjectgene expressiones_ES
dc.subjectmicroarrayes_ES
dc.titleKIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profilinges_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/cancers12102991


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional